White Lion Capital is a multi-strategy family office founded in 2019. We focus on making special opportunity investments into private and public companies of all sectors. We strive to create value-add relationships for our portfolio companies beyond capital.



The White Lion GBM innovation Fund supports pre-IND and clinical-stage biotech companies developing therapies for glioblastoma and other brain tumors, helping them advance toward key clinical milestones through collaboration with CROs, academic partners, and disease-focused nonprofits.
White Lion Capital proudly supports life science nonprofit organizations across all fields of medicine with an emphasis on Oncology. Our mission is to contribute to clinical research organizations, patient care and quality of life, and innovative clinical trials. We strive to bridge the gap of inefficiencies in healthcare so those impacted by diseases, cancer, and other medical problems can still live a fulfilled life.
